Literature DB >> 16400654

Autologous fibrin matrices: a potential source of biological mediators that modulate tendon cell activities.

Eduardo Anitua1, Mikel Sanchez, Alan T Nurden, Mar Zalduendo, Maria de la Fuente, Gorka Orive, Juan Azofra, Isabel Andia.   

Abstract

The use of autologous fibrin matrices has been proposed as a therapeutic strategy for the local and physiological delivery of growth factors in the treatment of several clinical conditions requiring tendon healing or tendon graft remodelling. In the present work, we investigated the proliferation, synthesis of type-I collagen and angiogenic factors by tendon cells seeded on platelet-rich (PR) and platelet-poor (PP) matrices. Furthermore, in vivo cellular and vascular effects of each treatment were examined after infiltration in Achilles tendon in sheep. Results showed that the presence of platelets within the fibrin matrices increased significantly the proliferation of tendon cells. Additionally, cultured tendon cells synthesised type I collagen and angiogenic factors such as VEGF and HGF. The synthesis of VEGF, but not of HGF, was significantly higher when platelets were present within the matrix. In the sheep model, the injection of pre-clotted plasma within tendons increased cellular density and promoted neovascularization. These results indicate that administration of fibrin matrices is a safe and easy strategy that may open new avenues for enhancing tissue healing and remodelling and influences the process of regeneration in clinical situations characterised by a poor healing outcome. Copyright (c) 2006 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16400654     DOI: 10.1002/jbm.a.30585

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  40 in total

1.  Effects of plasma rich in growth factors (PRGF) on biomechanical properties of Achilles tendon repair.

Authors:  Diego López-Nájera; Mónica Rubio-Zaragoza; Joaquín J Sopena-Juncosa; Eduard Alentorn-Geli; Ramón Cugat-Bertomeu; J Andrés Fernández-Sarmiento; Juan M Domínguez-Pérez; Montserrat García-Balletbó; Víctor J Primo-Capella; José M Carrillo-Poveda
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-08-14       Impact factor: 4.342

Review 2.  Augmenting tendon and ligament repair with platelet-rich plasma (PRP).

Authors:  Ting Yuan; Chang-Qing Zhang; James H-C Wang
Journal:  Muscles Ligaments Tendons J       Date:  2013-08-11

Review 3.  Concise review: adipose-derived stromal vascular fraction cells and platelet-rich plasma: basic and clinical implications for tissue engineering therapies in regenerative surgery.

Authors:  Pietro Gentile; Augusto Orlandi; Maria Giovanna Scioli; Camilla Di Pasquali; Ilaria Bocchini; Valerio Cervelli
Journal:  Stem Cells Transl Med       Date:  2012-02-22       Impact factor: 6.940

4.  Synergistic activity of platelet rich plasma and high volume image guided injection for patellar tendinopathy.

Authors:  Michele Abate; Luigi Di Carlo; Sandra Verna; Patrizia Di Gregorio; Cosima Schiavone; Vincenzo Salini
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2018-03-31       Impact factor: 4.342

5.  Healing of donor site in bone-tendon-bone ACL reconstruction accelerated with plasma rich in growth factors: a randomized clinical trial.

Authors:  Roberto Seijas; Marta Rius; Oscar Ares; Montserrat García-Balletbó; Iván Serra; Ramón Cugat
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-11-27       Impact factor: 4.342

6.  Platelet-rich plasma treatment improves outcomes for chronic proximal hamstring injuries in an athletic population.

Authors:  Ryan R Fader; Justin J Mitchell; Shaun Traub; Roger Nichols; Michelle Roper; Omer Mei Dan; Eric C McCarty
Journal:  Muscles Ligaments Tendons J       Date:  2015-02-05

7.  Angiogenic and innate immune responses triggered by PRP in tendon cells are not modified by hyperuricemia.

Authors:  Isabel Andia; Eva Rubio-Azpeitia
Journal:  Muscles Ligaments Tendons J       Date:  2014-11-17

8.  Temporal and Spatial Expression of TGF-b1 in the Early Phase of Patellar Tendon Healing after Application of Platelet Rich Plasma.

Authors:  Dimitris N Lyras; Konstantinos Kazakos; Konstantinos Tilkeridis; Anna Kokka; Athanasios Ververidis; Sotirios Botaitis; George Agrogiannis
Journal:  Arch Bone Jt Surg       Date:  2016-04

Review 9.  Platelet-rich therapies in the treatment of orthopaedic sport injuries.

Authors:  Mikel Sánchez; Eduardo Anitua; Gorka Orive; Iñigo Mujika; Isabel Andia
Journal:  Sports Med       Date:  2009       Impact factor: 11.136

10.  An integral approach to the etiopathogenesis of human neurodegenerative diseases (HNDDs) and cancer. Possible therapeutic consequences within the frame of the trophic factor withdrawal syndrome (TFWS).

Authors:  Salvador Harguindey; Gorka Orive; Ramón Cacabelos; Enrique Meléndez Hevia; Ramón Díaz de Otazu; Jose Luis Arranz; Eduardo Anitua
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.